Latest News

For its stock to take off, Samsara must transform customer value into profitable growth.

The conglomerate bought back its shares in June for around $488 each. Are they still a buy at a record?

You might be able to turn that $10,000 into $115,347 -- or more. (Or less.)

The power of dollars compounding over 20 years can turn a small dividend income into a huge one.

Investing in just this one exchange-traded fund (ETF) for the past 25 years could have set you up for serious financial security.

The stock has been on a great run this year.

Adagene (NASDAQ:ADAG) is advancing its masked anti-CTLA-4 antibody, ADG126, also known as muzastotug, in metastatic microsatellite-stable colorectal cancer (MSS CRC) and in a neoadjuvant investigator-sponsored trial in Singapore, Chief Strategy Officer Mickael Chane-Du said during a Chardan conferen

Bloom Energy has benefited from tailwinds from data centers for power solutions. Here's what the company must do to continue delivering for investors.

Exceeding expectations on the bottom line can't compensate for this shortcoming -- at least in some investors' eyes.

Many AI stocks beat the Nasdaq Composite this year, and these three picks look like they can repeat the feat in 2027.

Earnings jumped 22% last fiscal year. Why would I still want the stock around 12% cheaper?

These two healthcare ETFs offer investors exposure to some of medicine's biggest names, but their different approaches to investing could lead to very different results.

Annaly and AGNC are getting hit by rising rates; is that an opportunity for investors or a valid recognition of risk?

Just because you can multiply daily moves, doesn't mean you should.

The shocking part is that the gift is only a drop in the bucket compared to the founder's total wealth.

You don't have to wait until December to find out how much your Social Security check will grow.

Both stocks have soared in recent years.

Both of these biotech stocks could be appealing to income investors.

The AI software specialist is nearing a $10 billion year. Will its share price rise with its sales?

Amazon's stock popped after reporting strong AWS growth in Q2. I like the odds of history repeating.

Statistically speaking, tariffs have been bad news for Wall Street and consumers.

One class has a vote. Is that vote worth paying about 1% more for?

SpaceX’s AI business is booming. That has important implications for the broader industry.

There's a downside to a generous raise.

A bear market could be on the way, but the right strategy can protect your portfolio.